Literature DB >> 19752003

Nasal septum perforation in a breast cancer patient treated with bevacizumab.

A Pinto Marín, A Redondo Sánchez, E Espinosa Arranz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752003     DOI: 10.1093/annonc/mdp451

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

Review 1.  Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilance.

Authors:  Judi Anne B Ramiscal; Aminah Jatoi
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

2.  Clinical pathologic conference case 1: Wegener's granulomatosis.

Authors:  Susan Müller; Siema Eljack; John M DelGaudio
Journal:  Head Neck Pathol       Date:  2011-08-23

3.  Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients.

Authors:  Judi Anne B Ramiscal; Aminah Jatoi
Journal:  Acta Oncol       Date:  2010-11-26       Impact factor: 4.089

4.  Nasal septum perforation and bevacizumab.

Authors:  Derek G Power; Nancy E Kemeny
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.738

5.  Perforation of the Nasal Septum in a Colorectal Cancer Patient Treated With Aflibercept: A Case Report.

Authors:  Javier David Benitez Fuentes; Alfonso Lopez de Sa Lorenzo; Alberto Elpidio Calvo Elias; Carmen Toledano Rojas; Monica Granja Ortega
Journal:  Cureus       Date:  2022-07-12

6.  Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.

Authors:  A Mailliez; C Baldini; J T Van; V Servent; Y Mallet; J Bonneterre
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

7.  Innovative technique for large septal perforation repair and radiological evaluation.

Authors:  S Mocella; F Muia; P G Giacomini; D Bertossi; E Residori; S Sgroi
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-06       Impact factor: 2.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.